1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Abpro Bio Co., Ltd.
  6. Financials
    A195990   KR7195990007

ABPRO BIO CO., LTD.

(A195990)
End-of-day quote Korea Stock Exchange  -  05-26
855.00 KRW   -0.81%
2021Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding
CI
2021Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Valuation
Fiscal Period: December 2016 2017 2018 2019
Capitalization1 181 89985 96475 465142 117
Enterprise Value (EV)1 167 045124 141114 038168 596
P/E ratio 10 313x-7,39x-5,63x-2,75x
Yield ----
Capitalization / Revenue 3,67x1,87x1,28x4,45x
EV / Revenue 3,37x2,70x1,94x5,28x
EV / EBITDA 59,1x-13,5x61,4x-6,56x
Price to Book 1,66x0,88x0,72x1,21x
Nbr of stocks (in thousands) 73 49573 78996 379176 762
Reference price (KRW) 2 4751 165783804
Announcement Date 03/20/201803/19/201903/13/202003/22/2021
1 KRW in Million
Income Statement Evolution (Annual data)
Fiscal Period: December 2016 2017 2018 2019
Net sales1 49 52145 94458 85731 930
EBITDA1 2 826-9 1831 856-25 686
Operating profit (EBIT)1 1 050-12 519-4 144-30 149
Operating Margin 2,12%-27,2%-7,04%-94,4%
Pre-Tax Profit (EBT)1 647-11 949-11 080-37 098
Net income1 17,3-11 626-11 058-37 869
Net margin 0,04%-25,3%-18,8%-119%
EPS2 0,24-158-139-292
Dividend per Share ----
Announcement Date 03/20/201803/19/201903/13/202003/22/2021
1 KRW in Million
2 KRW
Balance Sheet Analysis
Fiscal Period: December 2016 2017 2018 2019
Net Debt1 -38 17738 57326 480
Net Cash position1 14 854---
Leverage (Debt / EBITDA) -5,26x-4,16x20,8x-1,03x
Free Cash Flow1 -1 970-12 052-719-11 882
ROE (Net Profit / Equities) -0,16%-10,7%-9,10%-29,4%
Shareholders' equity1 -11 048109 065121 457128 854
ROA (Net Profit / Asset) 0,43%-4,63%-1,49%-9,93%
Assets1 4 010251 363743 822381 187
Book Value Per Share2 1 4921 3231 085664
Cash Flow per Share2 28757,571,484,6
Capex1 1 6532 5351 3052 786
Capex / Sales 3,34%5,52%2,22%8,73%
Announcement Date 03/20/201803/19/201903/13/202003/22/2021
1 KRW in Million
2 KRW
Key data
Capitalization (KRW) 225 705 564 180
Capitalization (USD) 180 472 050
Free-Float 88,8%
Free-Float capitalization (KRW) 200 425 598 184
Free-Float capitalization (USD) 160 258 426
Avg. Exchange 20 sessions () 1 630 074 600
Avg. Exchange 20 sessions (USD) 0,00
Average Daily Capital Traded 1%
EPS & Dividend
Change in Enterprise Value/EBITDA